Endoscopic Surgery Unit, 1(st) Department of Obstetrics & Gynecology, "Alexandra" Hospital, National and Kapodistrian University of Athens, 80 Vasilissis Sofias Avenue, 11528 Athens, Greece.
Endoscopic Surgery Unit, 1(st) Department of Obstetrics & Gynecology, "Alexandra" Hospital, National and Kapodistrian University of Athens, 80 Vasilissis Sofias Avenue, 11528 Athens, Greece.
Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:42-49. doi: 10.1016/j.ejogrb.2021.12.038. Epub 2022 Jan 5.
More than 30 regimens, medical and surgical, have been described for the treatment of Cesarean Scar Pregnancies (CSPs). This study aims to collect and analyze data in the published literature regarding the hysteroscopic management of CSPs focusing on efficacy and complications. Using a protocol registered with Prospero (#CRD42021242314), the electronic databases PubMed/Medline, Scopus, Clinical-Trials.gov and the Cochrane Library were comprehensively searched, from their inception to June 2020. Medical Subject Headings terms such as caesarean ectopic, hysteroscopy and endoscopy were used for the identification of the relevant records. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed to design the present systematic review. Eligible articles assessing the role of hysteroscopy in CSP were considered the studies published in peer-reviewed journals. Any studies with less than 10 cases or articles that insufficiently detailed the treatment regimen, the outcomes, and the success rate, were excluded. Selected articles were assessed for the level of evidence, based on Oxford Centre for Evidence-based Medicine guidelines. The methodologic quality, including the risk of bias, was evaluated with the employment of the Effective Public Health Practice Project Quality Assessment Tool. Ten out of 613 studies were included in the present review comprising 812 women with CSP treated by hysteroscopy. The treatment modalities were divided into three categories: (i) hysteroscopic resection of CSP, (ii) hysteroscopy after preoperative use of HIFU and (iii) preoperative use of UAE before hysteroscopic treatment. The overall success rate of hysteroscopic treatment on CSP cases was 91%, whereas the rate of hemorrhage or excessive vaginal bleeding (>500 mL) and the rate of hysterectomy were 1.66% and 0.28% respectively. According to the results of this systematic review, hysteroscopy appears to be a safe and effective procedure for CSP management. Current findings are primarily based on retrospective studies with poor methodological quality. Multicenter, well-designed studies are needed to draw definite conclusions.
已有 30 多种医疗和手术方案被用于治疗剖宫产术后子宫瘢痕妊娠(CSP)。本研究旨在收集和分析已发表文献中有关 CSP 宫腔镜管理的数据,重点关注疗效和并发症。使用在 PROSPERO(注册号:CRD42021242314)注册的方案,全面检索了 PubMed/Medline、Scopus、Clinical-Trials.gov 和 Cochrane Library 电子数据库,检索时间从建库至 2020 年 6 月。使用剖宫产部位妊娠、宫腔镜和内窥镜等医学主题词来识别相关记录。本系统评价遵循了系统评价和荟萃分析的首选报告项目(PRISMA)指南。纳入评估宫腔镜在 CSP 中作用的文章为发表在同行评议期刊上的研究。排除了案例少于 10 例或未充分详细说明治疗方案、结果和成功率的文章。根据牛津循证医学中心指南评估入选文章的证据水平。采用有效公共卫生实践项目质量评估工具评估方法学质量,包括偏倚风险。10 篇文章(613 篇文章中的 10 篇)被纳入本综述,包括 812 例接受宫腔镜治疗的 CSP 患者。治疗方式分为 3 类:(i)CSP 的宫腔镜切除术,(ii)HIFU 术前宫腔镜,(iii)UAE 术前宫腔镜。CSP 宫腔镜治疗的总体成功率为 91%,而出血或过度阴道出血(>500mL)的发生率和子宫切除术的发生率分别为 1.66%和 0.28%。根据本系统评价的结果,宫腔镜似乎是一种安全有效的 CSP 管理方法。目前的研究结果主要基于方法学质量较差的回顾性研究。需要进行多中心、精心设计的研究来得出明确的结论。